Advertisement

Topics

JHL Biotech's Clinical Trial Application Accepted by China for Bevacizumab Biosimilar to Treat ...

18:22 EDT 16 Apr 2018 | BioMedReports - Blog

JHL is planning to conduct a Phase I pharmacokinetic study in healthy volunteers in Chinafollowed by a multinational Phase III efficacy study in non-small cell lung

Read more...

Original Article: JHL Biotech's Clinical Trial Application Accepted by China for Bevacizumab Biosimilar to Treat ...

NEXT ARTICLE

More From BioPortfolio on "JHL Biotech's Clinical Trial Application Accepted by China for Bevacizumab Biosimilar to Treat ..."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...